Clinical trial cancer patient in head scarf

ONCOLOGY CLINICAL
TRIAL EXPERTISE

ERT’s eClinical technology and service solutions help bring life-saving oncology drugs to patients faster. Our advanced data collection and analysis methods increase data quality, simplify patient participation and enable quicker, more informed decision making for both traditional and hybrid oncology trials.
LEARN MORE

ONCOLOGY CLINICAL TRIALS EXPERTISE


ERT’s eClinical technology and service solutions help bring life-saving oncology drugs to patients faster. Our advanced data collection and analysis methods increase data quality, simplify patient participation and enable quicker, more informed decision making for both traditional and hybrid oncology trials.



Do you have the solutions you need to address oncology trial challenges?

The oncology drug pipeline has grown by nearly 70% since 2013. As sponsors look for cures in this evolving therapeutic area, they face many challenges, including an average success rate of only 3.4%.*

ERT’s eClinical technologies and therapeutic expertise provide relief to sponsors of all sizes who want to empower their study teams. Using our tools, your teams can be more productive, confident, and in control of the bedrock of your patient trial: endpoint data. 

Choosing the right patient data capture technology increases your odds of sticking to timelines and budgets, enrolling the right patients, and collecting accurate, high-quality information.



How can I decentralize my oncology clinical trial using virtual technology?

SOLUTION: ERT’s virtual trial capabilities can improve the oncology patient experience by reducing travel and site visit requirements. We power at-home data collection with convenient, patient-centric solutions that ensure quality, fidelity, and timeliness of delivery. To learn more about our virtual capabilities, click here.

What can I do to accelerate my oncology study?

It takes approximately 10.5 years for an oncology drug to make it to market. Sadly, this isn’t quick enough for many cancer patients.

SOLUTION:

ERT’s library of eCOA oncology assessments gets you to software release within 5 weeks, while delivering more predictable timelines. 

Our centralized cardiac safety and imaging technologies automate inefficient and error-prone manual processes, including secure data transfer and verification of source documents. Our ability to centralize your oncology trial data can eliminate transcription errors and reduce other delays by shortening recruitment timelines and helping you achieve database lock faster.

In clinical trials, having the ability to make go/no-go decisions faster is vital when time is of the essence. With ERT’s Trial Oversight solution, you can keep your studies on track by viewing your study performance data in near real-time.

How can I optimize site performance?

SOLUTION: Motivated sites are more likely to achieve higher patient recruitment and retention levels. Sponsors and CROs can improve the site’s clinical trial experience by making participation as simple and convenient as possible.

ERT reduces site burden by simplifying participation and saving time. We provide 24/7 customer service support, flexible training as well as real-time monitoring of patient compliance and safety levels. Using a single login, sites can easily access their patient data and take advantage of automatic alerts when pre-set thresholds are reached on safety or compliance levels, enabling them to take action quickly.

How can I maximize patient enrollment and retention?

SOLUTION: In oncology trials, every patient counts. ERT’s advanced technology ensures you’re not excluding eligible patients for both cardiac safety reads and overreads

We also ensure patients are at the heart of protocol design to drive patient engagement and retention. Our science team advises on the most appropriate data capture solution to help:

  • Reduce site visits and time spent at site through, for example Virtual Video Visits, wearables or at-home blood pressure monitoring
  • Making participation easier: our choice of devices fit in with patients’ lifestyles and expectations and our patient engagement strategies include the use of notifications as well as motivational and educational messaging – all supporting high compliance levels

Using ERT’s Trial Oversight tools, you can effectively manage and monitor patient performance and risk to keep your oncology clinical trial on track.

Discover how to better motivate and engage oncology patients during a trial and their views on embracing digital data capture technology. Download our latest survey results

How can I use technology to reduce data collection and monitoring complexity in my trial?

The rise of precision medicine and targeted therapies has led to additional endpoints and eligibility criteria, as well as novel trial designs, such as basket and umbrella trials. These complexities not only impact sites and study teams but also contribute to decreased patient compliance and extended development timelines.

SOLUTION: ERT’s team of more than 100 scientific and regulatory experts will consult on your protocol design to ensure your methods for data collection reflect best practices. They’ll also provide study and device recommendations.

Then, getting your trial up and running couldn’t be faster or simpler with the pre-built libraries provided by our eCOA on-demand solution.

During the study, patients can complete their assessments on a device which suits them, including their own mobile device (through Bring Your Own Device, or BYOD), enhancing their experience, driving higher compliance levels, and overcoming some of the burdens that patients face when participating in today’s increasingly complex clinical trials.

Intuitive data visualizations produced by our Trial Oversight solution simplifies the analysis of high-volume, high-velocity, and high-complexity data.

Together, our technology and expertise can significantly simplify the clinical trial process for patients, sites and sponsors

Decentralized trials

SOLUTION: ERT’s virtual trial capabilities can improve the oncology patient experience by reducing travel and site visit requirements. We power at-home data collection with convenient, patient-centric solutions that ensure quality, fidelity, and timeliness of delivery. To learn more about our virtual capabilities, click here.

Oncology trials take 69% longer

It takes approximately 10.5 years for an oncology drug to make it to market. Sadly, this isn’t quick enough for many cancer patients.

SOLUTION:

ERT’s library of eCOA oncology assessments gets you to First-Patient-In 50% faster, while delivering more predictable timelines. Tox database. 

Our centralized cardiac safety and imaging technologies automate inefficient and error-prone manual processes, including secure data transfer and verification of source documents. Our ability to centralize your oncology trial data can eliminate transcription errors and reduce other delays by shortening recruitment timelines and helping you achieve database lock faster.

In clinical trials, having the ability to make go/no-go decisions faster is vital when time is of the essence. With ERT’s Trial Oversight solution, you can keep your studies on track by viewing your study performance data in near real-time.

Low site compliance and retention

SOLUTION: Motivated sites are more likely to achieve higher patient recruitment and retention levels. Sponsors and CROs can improve the site’s clinical trial experience by making participation as simple and convenient as possible.

ERT reduces site burden by simplifying participation and saving time. We provide 24/7 customer service support, flexible training as well as real-time monitoring of patient compliance and safety levels. Using a single login, sites can easily access their patient data and take advantage of automatic alerts when pre-set thresholds are reached on safety or compliance levels, enabling them to take action quickly.

Low patient enrollment

SOLUTION: In oncology trials, every patient counts. ERT’s advanced technology ensures you’re not excluding eligible patients for both cardiac safety reads and overreads

We also ensure patients are at the heart of protocol design to drive patient engagement and retention. Our science team advises on the most appropriate data capture solution to help:

  • Reduce site visits and time spent at site through, for example Virtual Video Visits, wearables or at-home blood pressure monitoring
  • Making participation easier: our choice of devices fit in with patients’ lifestyles and expectations and our patient engagement strategies include the use of notifications as well as motivational and educational messaging – all supporting high compliance levels

Using ERT’s Trial Oversight tools, you can effectively manage and monitor patient performance and risk to keep your oncology clinical trial on track.

Discover how to better motivate and engage oncology patients during a trial and their views on embracing digital data capture technology. Download our latest survey results

Increasing complexity with more endpoints

The rise of precision medicine and targeted therapies has led to additional endpoints and eligibility criteria, as well as novel trial designs, such as basket and umbrella trials. These complexities not only impact sites and study teams but also contribute to decreased patient compliance and extended development timelines.

SOLUTION: ERT’s team of more than 100 scientific and regulatory experts will consult on your protocol design to ensure your methods for data collection reflect best practices. They’ll also provide study and device recommendations.

Then, getting your trial up and running couldn’t be faster or simpler with the pre-built libraries provided by our eCOA on-demand solution.

During the study, patients can complete their assessments on a device which suits them, including their own mobile device (through Bring Your Own Device, or BYOD), enhancing their experience, driving higher compliance levels, and overcoming some of the burdens that patients face when participating in today’s increasingly complex clinical trials.

Intuitive data visualizations produced by our Trial Oversight solution simplifies the analysis of high-volume, high-velocity, and high-complexity data.

Together, our technology and expertise can significantly simplify the clinical trial process for patients, sites and sponsors


*Chi Heem Wong, Kien Wei Siah, Andrew W Lo. “Estimation of clinical trial success rates and related parameters.” Biostatistics 20(2): April 2019, Pages 273-286. Published online: 31 January 2018. DOI: 10.1093/biostatistics/kxx069


5 WEEKS TO FIRST PATIENT-IN WITH ERT eCOA

ERT’s library of pre-built commonly used eCOA oncology assessments gets you from study design to software release in just 5 weeks.




TAKE CONTROL OF STUDY PERFORMANCE

ERT’s Trial Oversight suite collects, normalizes, and analyzes trial data to uncover holistic insights into study performance, patient retention, and risk management. Our proven monitoring tools enable you to identify potential patient safety and study issues so you can make more informed, proactive decisions.


ERT ONCOLOGY EXPERIENCES


150 APPROVALS
330K PATIENTS
70K+ SITES
2K TRIALS

CARDIAC SAFETY

ERT’s centralized Cardiac Safety solution helps you maximize patient recruitment in oncology trials by ensuring only the correct patients are enrolled – and that none are incorrectly excluded.


IMAGING

ERT’s advanced imaging solution accelerates oncology trials by leveraging guided-read technology to minimize human error associated with important safety and efficacy data reads and overreads.


POST-APPROVAL

ERT’s Post-Approval patient data capture oncology solution is designed with longevity, simplicity and patient centricity in mind.


eCOA

ERT’s eCOA solution gets you to first-patient-in 50% faster, accelerating study start-up. We also ensure that our solution is designed around the unique needs of cancer patients, simplifying participation and reducing the need for site visits and time spent at site.

Slide

This survey explores the acceptance of digital technology for clinical research amongst oncology patients.

Oncology Patient Data: Digital Health Preferences & Motivations

LEARN MORE eBook
Slide

ERT’s eCOA solution provided efficient deployment of eCOA assessments across oncology studies in various indications.

High-Quality eCOA Data Across Group of Oncology Studies

LEARN MORE Case Study
Slide

Regulatory agencies are also placing weight on the importance of PRO-based secondary endpoints that are indicative of clinical benefit.

Patient-Reported Outcome (PRO) Data in Oncology Trials

LEARN MORE Blog
Slide

This article presents how sponsors can optimize imaging processes in oncology clinical trials

Cardiac Imaging in Oncology Trials

LEARN MORE News
Slide

Learn how relying on ECG machine QTc measurements during oncology trials can impact dosing decisions.

Benefits of Centralized ECGs in Oncology

LEARN MORE White Paper
Slide

Learn how imaging evaluations (e.g. CT/MRI) can be used as outcome endpoints to determine efficacy in oncology clinical trials.

Oncology Imaging Innovations

LEARN MORE News
Slide

Web portal provides ideal solution for 8-year, large scale observational study.

Pharma company adopts ‘light touch’ approach for multiple myeloma registry

LEARN MORE Case Study

TALK TO A SPECIALIST

With decades and thousands of trials worth of experience, ERT has the knowledge and flexibility to provide proven eClinical technology solutions for your next oncology trial or post-approval study. To find out how our technology or services can fit your protocol, submit a contact form. A member of our team will be in touch with you shortly.